AstraZeneca in defensive mode on Covid vaccine trials following U.S critics
Following the criticism from experts in the U.S., AstraZeneca defends the outcomes and methods used in their phase three vaccine trials, stressing the “best quality” were used and that additional research will be carried out. After concerns were raised about its vaccine candidate, AstraZeneca shares are down by about 6 percent this week, for which […]
